Odonate
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Odonate and buy or sell other stocks, ETFs, and their options commission-free!About ODTC
Odonate, Inc. is a pharmaceutical company, which engages in the development of therapeutics that improve and extend the lives of patients with cancer. It focuses on the development of tesetaxel, a novel chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer.
CEOKevin C. Tang
CEOKevin C. Tang
Employees—
Employees—
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2013
Founded2013
Employees—
Employees—
ODTC Key Statistics
Market cap321.82M
Market cap321.82M
Price-Earnings ratio-0.83
Price-Earnings ratio-0.83
Dividend yield—
Dividend yield—
Average volume1.70
Average volume1.70
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$4,840.00
52 Week high$4,840.00
52 Week low$3,000.00
52 Week low$3,000.00
Stock Snapshot
With a market cap of 321.82M, Odonate(ODTC) trades at $22,005.00. The stock has a price-to-earnings ratio of -0.83.
On 2026-02-16, Odonate(ODTC) stock opened at —, reached a high of —, and a low of —.
Odonate(ODTC) shares are trading with a volume of 0, against a daily average of 1.7.
In the last year, Odonate(ODTC) shares hit a 52-week high of $4,840.00 and a 52-week low of $3,000.00.
In the last year, Odonate(ODTC) shares hit a 52-week high of $4,840.00 and a 52-week low of $3,000.00.